C
arbapenems are the last-resort antibiotics against drug-resistant Gram-negative bacterial pathogens (1) . However, carbapenem-resistant Enterobacteriaceae (CRE) are increasingly reported in health care-associated infections (HAIs) and are considered an urgent threat to human health by the Centers for Disease Control in the United States (2) . Multiple genes conferring carbapenem resistance have been reported, which encode various types of carbapenemases (1) . New Delhi metallo-␤-lactamase 1 (NDM-1), an Ambler class B metallo-␤-lactamase (MBL), hydrolyzes all ␤-lactams (including carbapenems) but monobactams and was first identified in Klebsiella pneumoniae and Escherichia coli isolated from a Swedish patient who was hospitalized in India in 2008 (3) . Subsequently, the wide distribution of NDM-1-producing Enterobacteriaceae in India, Pakistan, and the United Kingdom was reported (4) , and the Indian subcontinent was considered the main reservoir of NDM-1 producers (5). To date, the NDM-1-producing pathogens have been reported in more than 40 countries and have become a significant threat for public health worldwide (6) .
In China, the bla NDM-1 gene was first identified in four nonclonal Acinetobacter baumannii isolates (7) . Subsequent studies found that Acinetobacter spp. were the main species carrying this gene, but the carriage of bla NDM-1 was at a low frequency (Ͻ1.5%) (7) (8) (9) . Carbapenem resistance in Enterobacteriaceae in China has been mainly associated with Klebsiella pneumoniae carbapenemases (KPCs), such as KPC-2, and MBLs (such as IMP-4) other than NDM-1 (10, 11) . NDM-1-mediated carbapenem resistance in Enterobacteriaceae in China has been rarely reported; so far there have been only two confirmed cases of NDM-1-producing K. pneumoniae and E. coli infections in China (12, 13) . A recent study detected a high infection rate (14.8%) of NDM-1-producing bacteria in clinical fecal samples from multiple hospitals in China, but none of the NDM-1-carrying bacteria belonged to Enterobacteriaceae (14) . These observations suggested that NDM-1 was not prevalent in CRE isolates from China. However, in this study, we demonstrated the high incidence and endemic spread of NDM-1-producing Enterobacteriaceae in Henan Province in China. Additionally, we conducted molecular characterization of the bla NDM-1 -positive CRE isolates, revealing new molecular epidemiological features of CRE in China.
MATERIALS AND METHODS
Bacterial isolates, identification, and antimicrobial susceptibility testing. A total of 48 CRE (imipenem [MIC, Ն4 g/ml] or meropenem [MIC, Ն2 g/ml]) isolates, including 6 E. coli, 33 K. pneumoniae, 1 Klebsiella oxytoca, 5 Enterobacter cloacae, and 3 Citrobacter freundii isolates, were collected from diagnostic laboratories in three hospitals located in the middle (Zhengzhou, n ϭ 40), western (Sanmenxia, n ϭ 4), and southern (Zhumadian, n ϭ 4) regions of Henan Province (north-central China). These isolates were obtained from June 2011 to July 2012. All isolates were identified using the Vitek 2 system (bioMérieux, France) and 16S rRNA gene sequencing. Antimicrobial susceptibilities for the bla NDM-1 -positive isolates and transconjugants were initially tested using the Vitek 2 system (bioMérieux, France) and then were followed by measuring the MIC using the broth microdilution method (for ampicillin-sulbactam, piperacillin-tazobactam, cefazolin, cefotetan, ceftazidime, cefepime, imipenem, ertapenem, ciprofloxacin, levofloxacin, gentamicin, amikacin, and aztreonam), the Etest (AB bioMérieux, Sweden) (for chloramphenicol, tetracycline, tigecycline, and colistin), and the agar dilution method (for fosfomycin), respectively. The standard microbroth and agar dilution methods were performed according to the guideline M07-A9 of the Clinical and Laboratory Standards Institute (CLSI) (15) . Etests were conducted according to packet insert instructions using Mueller-Hinton agar (MHA). Fresh bacterial colonies taken directly from MHA plates that were incubated at 37°C for 16 to 20 h were resuspended in sterile MuellerHinton broth to obtain a suspension with McFarland standard 0.5 turbidity. E. coli ATCC 25922 was used as the quality control. The MIC results were interpreted according to the CLSI guideline M100-S22 (15) . The 2013 European Committee on Antimicrobial Susceptibility Testing breakpoints were used (available at http://www.eucast.org/clinical_breakpoints/) for colistin and tigecycline.
Detection of resistance determinants. The modified Hodge test and the imipenem-EDTA double-disk synergy test were performed according to the CLSI guidelines to detect carbapenemase activity (15) . PCR and nucleotide sequencing were employed to screen for the presence of carbapenemase-encoding genes, including bla OXA-48 -like , bla IMP , bla VIM , bla KPC , and bla NDM . In addition, extended-spectrum ␤-lactamase (ESBL) genes, plasmid-mediated AmpC genes, 16S rRNA methyltransferase genes, and fosfomycin resistance determinants were also detected by use of the methods described previously (16) (17) (18) (19) (20) .
Bacterial genotyping. Pulsed-field gel electrophoresis (PFGE) of XbaI-digested genomic DNA of bla NDM-1 -positive CRE and reference marker Salmonella H9812 was performed using a contour-clamped homogeneous electric field (CHEF)-Mapper XA PFGE system (Bio-Rad, USA) with a 5-to 35-s linear ramp for 22 h at 6 V/cm at 14°C. The running buffer was 0.5ϫ Tris-boric acid-EDTA (TBE) without thiourea. The gel image was captured using a Bio-Rad Universal Hood II gel imaging system (Bio-Rad, USA). The dendrograms were constructed from the PFGE data by the unweighted-pair group method with arithmetic mean (UPGMA) with the Dice coefficient using InfoQuest FP software version 4.5 (BioRad Laboratories, USA). Multilocus sequence typing (MLST) for clinical K. pneumoniae and E. coli isolates was performed following the methods described previously (21, 22) . The allelic profiles and sequence types (STs) were assigned using online databases (see http://www.pasteur.fr /recherche/genopole/PF8/mlst/Kpneumoniae.html for K. pneumoniae and http://mlst.warwick.ac.uk/mlst/dbs/Ecoli for E. coli).
Conjugation and plasmid analysis. Conjugative assays were performed according to the method described previously (23) . The bla NDM-1 -positive CRE served as the donors, while E. coli J53 (sodium azide resistant) was used as the recipient strain. Transconjugants were selected on MuellerHinton (MH) agar supplemented with sodium azide (100 g/ml) and imipenem (1 g/ml). The presence of the bla NDM-1 gene and other resistance genes in transconjugants were identified using PCR and DNA sequencing, and antimicrobial susceptibility was also determined. S1-PFGE and Southern blotting were conducted to estimate sizes of bla NDM-1 plasmids (24) . Briefly, whole-cell DNA of clinical and transconjugant strains in agarose gel plugs was treated with S1 nuclease (TaKaRa, Dalian, China), then separated by PFGE under the following conditions: 0.5ϫ Tris-borate-EDTA, 1% agarose solution for 18 h at 6 V/cm and 14°C, with a pulse angle of 120°and the pulse time linearly ramped from 2.16 s to 63.8 s. Linear plasmids generated by S1-PFGE were transferred to nylon membranes (Millipore, USA), hybridized with digoxigenin-labeled bla NDM-1 -specific probes, and detected using a nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate (NBT-BCIP) color detection kit (Roche Applied Sciences, Germany) according to the recommendations of the supplier. Plasmid replicons were determined using the PCR-based replicon typing method (25) . The genetic environment surrounding bla NDM-1 was investigated by PCR mapping and sequencing, and the Acinetobacter lwoffii plasmid of pNDM-BJ01 (accession no. JQ001791) and E. coli plasmid of pBJ01 (GenBank accession no. JX296013) were used as the references. PCR primers were designed from the reference sequences and are listed in Table S1 in the supplemental material. The locations of the primers are also shown (see Fig. 3 ).
Nucleotide sequence accession number. The sequence described in this paper has been submitted to GenBank under the accession no. KF985036 (K. oxytoca isolate ZMD8).
RESULTS AND DISCUSSION
Identification of bla NDM-1 -positive isolates from hospital patients. Among the 48 CRE, 16 (16/48 [33.3%]) were identified as bla NDM-1 positive, including 6 E. coli, 4 K. pneumoniae, 1 K. oxytoca, 3 E. cloacae, and 2 C. freundii isolates, which were obtained from specimens of blood (n ϭ 7), urine (n ϭ 6), and sputum (n ϭ 2) and a burn site (n ϭ 1) (Table 1) . Additionally, 26 K. pneumoniae isolates harbored bla KPC-2 , 2 isolates (1 K. pneumoniae and 1 E. cloacae) carried bla , and the remaining isolates did not contain the carbapenemase genes (bla NDM , bla KPC , bla VIM , bla IMP , and bla OXA-48-like ) screened in this study. The 16 bla NDM-1 -positive CRE were from three hospitals in three different cities in Henan Province. The clinical data associated with the 16 isolates were summarized in Table 1 . These patients were diagnosed with different clinical diseases, but none of the patients had a history of foreign travel. Notably, 5 patients, including 3 young children, died of infections. All of the patients who died, except an infant, had a positive blood culture for CRE and two of the patients had septicemia (Table 1) . Thus, the death rate among the patients infected with a bla NDM-1 -positive isolate was 31%, which is higher than previously reported rates in confirmed cases associated with NDM-1-producing bacteria worldwide (26) . These results revealed the high prevalence of bla NDM-1 -positive CRE in the hospitals of Henan Province and their association with a high mortality rate. Antimicrobial susceptibility patterns and resistance determinants. All of the NDM-1-positive CRE isolates were resistant to carbapenems and cephalosporins but susceptible to colistin (MICs of Յ2 mg/liter) ( Table 2 ). Molecular characterization showed that most of the E. coli (5/6) and half of the K. pneumoniae isolates (2/4) harbored ESBL genes, AmpC genes, or both (Table  1 ). Other carbapenemase-encoding genes, including bla KPC , bla VIM , bla IMP , and bla OXA-48-like , were not detected in any of the NDM-1-positive CRE isolates. Six isolates (EC-24, KP-07, KP-09, KP-40A, KP-41, and ZMD12) demonstrated tigecycline resistance according to the EUCAST clinical breakpoint, with MICs of Ն2 g/ml (Table 2 ). More significantly, five isolates, including EC-03, CF-25, ECL-ZMD10 (susceptible only to tigecycline and colistin), EC-24 (susceptible only to amikacin and colistin), and ECL-ZMD12 (susceptible only to fosfomycin and colistin), were identified as extensively drug-resistant (XDR) bacteria (nonsusceptible to Ն1 agent in all of the 17 but Յ2 antimicrobial categories, including glycylcyclines and polymyxins used for treatment of infections caused by Enterobacteriaceae) according to the definitions described by Magiorakos et al. (27) . In addition, four isolates (EC-03, EC-24, ECL-ZMD10, and CF-25) harbored a plasmid-mediated fosfomycin resistance gene, fosA3. This gene was found only in CTX-M-producing E. coli isolated from Asian countries (28) , and our finding represents the first report of NDM-1-producing CRE harboring the fosA3 gene encoding fosfomycin resistance. Generally, the resistance rate of fosfomycin in E. coli was low (1% to 3%) worldwide, and fosfomycin is also used as an alternative choice for treating infections caused by ESBL-producing and even carbapenemase-producing Enterobacteriaceae (29) . However, the occurrence of fosfomycin resistance in NDM-1-producing CRE observed in this study will further limit clinical therapeutic options.
Genotyping. PFGE was successfully performed with 4 E. coli, 3 K. pneumoniae, 1 K. oxytoca, 3 E. cloacae, and 2 C. freundii isolates, and their patterns were completely different (Fig. 1) . Three isolates, including EC-24, EC-SMX5, and KP-40A, were nontypeable by PFGE, as their XbaI-digested genomic DNA failed to yield distinct bands despite multiple efforts to repeat the experiment. MLST was performed for all of the bla NDM-1 -positive E. coli and K. pneumoniae isolates, since the two species of Enterobacteriaceae were the major ones carrying the bla NDM-1 gene. Five MLST types were identified among the six E. coli isolates. Similarly, four MLST types were identified among the four K. pneumoniae isolates (Table 1) . Two E. coli isolates (EC-03 and EC-SMX5) obtained from two different hospitals located in geographically separated areas (Zhengzhou and Sanmenxia) shared the same ST type (ST361), suggesting they were clonally related. Overall, our data showed that clonally diverse NDM-1-producing Enterobacteriaceae contributed to the dissemination of bla NDM-1 in Henan Province.
This study linked for the first time six new STs (ST40, ST205, and ST1237 [E. coli] and ST113, ST889, and ST966 [K. pneumoniae]) to the production of NDM-1. E. coli ST410 and K. pneumoniae ST11 were frequently detected in clinical isolates of NDM-1-producing E. coli and K. pneumoniae from different countries, suggesting that they play an important role in the dissemination of bla NDM-1 (30) . In addition, the NDM-1-producing E. coli ST361 isolate was also found in New Zealand (31) .
Plasmid analysis. S1-PFGE and Southern blot analysis showed that the presence of the bla NDM-1 gene in the 16 CRE isolates was located on diverse plasmids, with sizes ranging from ϳ55 to ϳ360 kb. Furthermore, half of the bla NDM-1 plasmids belonged to plasmid replicon type IncA/C (Table 1 and Fig. 2 ). This broad-hostrange plasmid was most frequently reported for carrying bla NDM-1 and other resistance genes, and it is widely disseminated among Gram-negative bacteria worldwide (6, 32) .
Conjugative assays revealed that all of the bla NDM-1 plasmids were successfully transferred to E. coli J53 from the 16 donors by conjugation. The 16 transconjugants all showed resistance to carbapenems and cephalosporins (Table 2) . Moreover, the bla NDM-1 plasmids in all the transconjugants remained stable after 10 passages in the absence of imipenem selection. In addition, resistance genes such as bla TEM-1 , bla CTX-M-15/55 , bla CMY-30 , rmtB, armA, and fosA3 were cotransferred to E. coli J53 with the bla NDM-1 gene in several isolates (Table 2) . Interestingly, we found that the bla NDM-1 and fosA3 genes were carried by distinct IncA/C plasmids in EC-03 (ϳ180 kb for bla NDM-1 and ϳ90 kb for fosA3) and CF-25(ϳ170 kb for bla NDM-1 and ϳ310 kb for fosA3) (Fig. 2) , but the two plasmids in each isolate were cotransferred to the E. coli J53 recipient, suggesting that both were mobile or one of them acted as a helper plasmid for the other to transfer. In contrast to the above two isolates, ECL-ZMD10 harbored a large plasmid (ϳ360 kb) of an untypeable replicon type, which carried both bla NDM-1 and fosA3 and was transferred to E. coli J53 by conjugation ( Fig. 2 and Table  2 ). Several recent studies demonstrated that the fosA3 gene was associated with bla CTX-M genes and carried by plasmids belonging to different replicon types, including F, N, B/O, and I1 in E. coli and K. pneumonia (33) (34) (35) . In our study, this gene was found to be carried by a conjugative bla NDM-1 plasmid in a species (E. cloacae) other than E. coli and K. pneumonia, implying the further spread of fosA3 among Enterobacteriaceae. Moreover, the E. coli J53 recipient became an XDR strain after accepting the ECL-ZMD10 plasmid by conjugation, indicating multiple resistance determinants might be carried by this bla NDM-1 plasmid. Additional studies are ongoing to characterize this plasmid. In vivo interspecies dissemination of IncA/C plasmids carrying bla NDM-1 was described in previous studies (23, 36) . However, all of the NDM-1 plasmids identified in the 16 bla NDM-1 -positive CRE isolates were different either in size or replicon type, suggesting that insertion elements or transposons may play important roles in the mobilization of bla NDM-1 .
Genetic environments of bla NDM-1 . The genetic environments surrounding the bla NDM-1 gene were detected by PCR mapping and DNA sequencing. The bleomycin resistance gene ble MBL , followed by a truncated trpF gene, was located immediately downstream of the bla NDM-1 gene in all of the 16 CRE isolates (Fig. 3) . The three-gene cluster (bla NDM-1 -ble MBL -⌬trpF) was highly conserved and was also previously reported in E. coli plasmids (pNDM-HK, pBJ01, and pNDM_Dok01) and A. lwoffii plasmids (pNDM-BJ01 and pNDM-BJ02) (37) (Fig. 3) . It was reported that bla NDM-1 and ble MBL are under the control of the same promoter in front of bla NDM-1 , and this structure may facilitate the spread of NDM-1 when under the selective pressure of bleomycin-like mol- ecules in the environment (38) . The entire ISAba125 element was detected immediately upstream of the bla NDM-1 gene in each of the 16 isolates. It has been documented that ISAba125 provides the Ϫ35 region of the promoter sequence for bla NDM-1 in all reported cases (37) . For two K. pneumonia isolates (KP-09 and KP-41) and one K. oxytoca isolate (KO-ZMD8), a 5,859-bp DNA segment was sequenced and it contained eight genes, including ISAba125, bla NDM-1 , ble MBL , ⌬trpF, dsbC, cutA1, groES, and groEL (Fig. 3) . This DNA segment is highly homologous (Ͼ99%) to previously identified sequences in Acinetobacter spp. from China (9, 39) (Fig.  3) , suggesting the possible transmission of bla NDM-1 -containing sequences between Acinetobacter spp. and Enterobacteriaceae. Considering that bla NDM-1 was mostly reported in Acinetobacter spp. in China, our finding suggests that Acinetobacter may have served as a reservoir for the dissemination of NDM-1 toward Enterobacteriaceae.
The sporadic emergence of NDM-1-producing E. coli and K. pneumoniae in mainland China has been reported in two recent studies (12, 13) . Additionally, several cases of NDM-1-producing CRE reported from Hong Kong and Taiwan were also epidemiologically linked to mainland China (40) (41) (42) . Here, we report our study of a cluster of bla NDM-1 -positive CRE from patients in Henan Province. Together, these findings strongly suggest that NDM-1-producing CRE is spreading in mainland China. Compared to previously reported studies, our work revealed several important findings on CRE in China. First, a high incidence (33.3%) of NDM-1-producing Enterobacteriaceae was observed among the examined CRE, which is much higher than previously realized and suggests that bla NDM-1 -positive CRE is endemic in Henan Province. Second, none of the patients carrying NDM-1-producing CRE had a history of foreign travel, suggesting that the NDM-1-carrying CRE were endogenous to the region and likely originated locally due to antibiotic selection and spread of the resistance gene. Third, most of the NDM-1-producing E. coli and K. pneumoniae isolates identified in this study belong to new MLST sequence types that have not been reported previously, suggesting the active spread of bla NDM-1 among Enterobacteriaceae in China. These findings provide new insights into the epidemiology of CRE in China.
In summary, our study demonstrated a high incidence of NDM-1-producing CRE from patients with different clinical diseases in Henan Province. These NDM-1-positive isolates were genetically diverse and carried plasmids of various sizes that were readily transferred by conjugation. Our results suggest that mainland China is becoming an endemic reservoir for NDM-1-producing Enterobacteriaceae. In addition, the emergence of XDR Enterobacteriaceae carrying conjugative bla NDM-1 plasmids coharboring other resistance determinants such as fosA3 is alarming, as spread of these isolates will seriously limit options for clinical treatment in future. Thus, enhanced efforts are urgently needed to control the further spread of NDM-1-producing Enterobacteriaceae.
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